טוען...
Inhaled corticosteroids with combination inhaled long‐acting beta(2)‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
BACKGROUND: Management of chronic obstructive pulmonary disease (COPD) commonly involves long‐acting bronchodilators including beta‐agonists (LABA) and muscarinic antagonists (LAMA). In individuals with persistent symptoms or frequent exacerbations, inhaled corticosteroids (ICS) are also used. LABA...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2016
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464947/ https://ncbi.nlm.nih.gov/pubmed/27830584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011600.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|